Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Accessible Approach to Molecular and Biomarker Testing for Risk Stratification in Oral Cavity Squamous Cell Carcinoma. | Head Neck Pathol | 2026 | 42758366 | PubTator, text mining | PubMed |
| Clinicopathologic and molecular characteristics of acral melanomas harboring RARA fusions. | Hum Pathol | 2026 | 42398544 | PubTator, text mining | PubMed |
| Comparative Genomic Profiling and Prognostic Impact in Recurrent and/or Metastatic Hypopharyngeal and Esophageal Squamous Cell Carcinoma. | Laryngoscope Investig Otolaryngol | 2026 | 42257210 | PubTator, text mining | PubMed |
| Comprehensive Genomic Characterization Between Urothelial Carcinoma Subtypes/Divergent Differentiation (S/DD) and Pure Urothelial Carcinoma Using a Large-Scale Japanese Genomic Panel Dataset. | Int J Urol | 2026 | 42252959 | PubTator, text mining | PubMed |
| Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial. | Nat Med | 2026 | 42191879 | PubTator, text mining | PubMed |
| A novel prognostic biomarker combining TP53 loss-of-function and amplification of different combinations of nine genes in lung squamous cell carcinoma treated with chemotherapy. | Oncol Lett | 2026 | 42164467 | PubTator, text mining | PubMed |
| ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival. | ESMO Rare Cancers | 2026 | 41994103 | PubTator, text mining | PubMed |
| Molecular characteristics of proximal and distal esophagogastric junction adenocarcinoma. | J Thorac Dis | 2026 | 41988313 | PubTator, text mining | PubMed |
| Short-term response to alectinib and rapid progression in a lung squamous cell carcinoma patient harboring an EML4-ALK fusion: a case report. | Transl Cancer Res | 2026 | 41969449 | PubTator, text mining | PubMed |
| Research progress in heterogeneity of dental mesenchymal stem cells. | Int J Oral Sci | 2026 | 41932866 | PubTator, text mining | PubMed |
| Establishing Area-Specific Brain Organoids Through Transcription Factor-Mediated Patterning. | Biology (Basel) | 2026 | 41892247 | PubTator, text mining | PubMed |
| Molecular and Clinical Profile of a RET-Rearranged Colorectal Cancer With Prolonged Response to Platinum Therapy and Subsequent Targeted Treatment With Selpercatinib. | JCO Precis Oncol | 2026 | 41881065 | PubTator, text mining | PubMed |
| Synergistic electronic-topological strategy enables spatiotemporal control of covalent adaptable networks. | Sci Adv | 2026 | 41849606 | PubTator, text mining | PubMed |
| FGF family in health and disease. | Mol Biomed | 2026 | 41832306 | PubTator, text mining | PubMed |
| Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities. | Cancer | 2026 | 41761743 | PubTator, text mining | PubMed |
| Photocatalytic Synthesis of (Hetero)biaryls via Palladium-Catalyzed Hybrid-Radical Cross-Coupling of (Hetero)aryl Halides and C-H Functionalization of Heteroarenes. | JACS Au | 2026 | 41755836 | PubTator, text mining | PubMed |
| Nasopharyngeal Carcinoma at the Virology Precision Oncology Nexus: Decoding Molecular Alterations for Early Intervention and Therapeutic Innovation. | Biomolecules | 2026 | 41750326 | PubTator, text mining | PubMed |
| Assessing the Impact of Comprehensive Genomic Profiling on Therapeutic Selection for Advanced Solid Tumors in Portugal. | Curr Oncol | 2026 | 41744832 | PubTator, text mining | PubMed |
| Somatic structural variants drive upper tract urothelial carcinoma muscle invasiveness via activation of TPX2 transcription. | EBioMedicine | 2026 | 41740229 | PubTator, text mining | PubMed |
| Catalyst-Controlled Regio- and Enantioselective Hydrophosphination of α,β-Unsaturated Pyridyl Ketones. | ACS Omega | 2026 | 41726724 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers